Matthew De Silva

128 posts

Matthew De Silva banner
Matthew De Silva

Matthew De Silva

@MDe_Silva

COO at Pathos AI, Venture Partner at Builders VC (Healthcare/Life Sciences), and Founder at Notable Labs

Chicago, IL Katılım Mayıs 2009
312 Takip Edilen601 Takipçiler
Matthew De Silva retweetledi
Jack O'Meara
Jack O'Meara@Jack_O_Meara·
Delighted to share the news of our partnership with @BoehringerIN. This is largely the hard work of @jackcastle, Quin Wills and the wider R&D team. I feel v grateful to work with such talented people to improve treatment options for liver disease patients. endpts.com/boehringer-ing…
English
19
9
137
10.7K
Matthew De Silva retweetledi
Ethan Perlstein 1-to-N
Ethan Perlstein 1-to-N@eperlste·
Waiting till your 40s or 50s to be a first-time biotech CEO is terrible advice to give young scientist entrepreneurs. You’re supposed to be in your 20s and 30s when you start your first company! That’s the fucking point: learn, fail, pivot, again and again and again.
English
9
5
58
10.7K
Matthew De Silva
Matthew De Silva@MDe_Silva·
@chrisfhoward Congratulations Chris! You will have an extremely fortunate set of new portfolio founders :)
English
1
0
2
314
Matthew De Silva retweetledi
Chris Howard
Chris Howard@chrisfhoward·
Today, I’m thrilled to announce the launch of my new firm, Ritual Capital, a $38M seed-stage venture firm investing collaborative $300k checks in exceptional founding teams building iconic, enduring companies. ritualcapital.com
Chris Howard tweet media
English
149
76
1.1K
355.8K
Matthew De Silva retweetledi
Enveda
Enveda@lifeschemistry·
We are proud to be selected by the @endpts editorial team as one of the most promising and ambitious #biotech startups! We’re grateful for the recognition of what we’ve built so far and where we are headed next: the clinic in 2024! endpts.com/the-endpoints-…
Enveda tweet media
English
2
12
60
12.7K
Viswa Colluru
Viswa Colluru@viswacolluru·
Today, we announced our Series B funding round, and I can't help but reflect on the journey that brought us here. In 2019, we had just an old laptop and $225,000 in funding. We had a fear of the unknown and a big dream to change where we look for new medicines. 1/
Enveda@lifeschemistry

Today we're proud to announce our Series B financing, led by Dimension with participation by @SVB_Financial and a deep bench of new and previous investors. Check out the @endpts piece and 🧵👇 for more on what we've built so far and what's coming next /1 (shorturl.at/oHMT8)

English
10
11
94
30.6K
Matthew De Silva retweetledi
Michelle Stephens
Michelle Stephens@mddstephens·
Catch me 11am tomorrow in The Newsroom at #HLTH2022 where I drop some unpopular facts about the state of maternal and child health in the US - tl;dr I am the statistic
English
0
1
13
0
Ethan Perlstein 1-to-N
Ethan Perlstein 1-to-N@eperlste·
Last week was a scientific first for drug repurposing! Monday AM: receive yeast hit list Monday PM: yeast hits independently confirmed in patient derived iPSC astrocyte/neuron Tuesday: family orders top hit OTC, doses child Wednesday: first babbling since it was lost at 8 months
English
16
22
208
0
Matthew De Silva retweetledi
Jacob Effron
Jacob Effron@jacobeffron·
A new software stack is emerging for the $230B life sciences R&D industry to match the incredible scientific progress of the past decade. I explored the new workflow, infrastructure and AI tools behind this stack here: vitalsignshealth.substack.com/p/the-changing…
Jacob Effron tweet media
English
29
158
705
0
Matthew De Silva retweetledi
BIOS
BIOS@bios_community·
BIOS — Top 100 TechBio VC Funds 🧬 As TechBio reaches critical mass, we thought it time to centralize the world of TechBio VC into one sheet We hope this database becomes a useful resource & serves as a go to for founders raising VC Funding… ow.ly/GCCy50KSvaO
BIOS tweet media
English
5
26
109
0
Matthew De Silva retweetledi
ENDPOINT HEALTH
ENDPOINT HEALTH@endpointhealth·
We are delighted to announce that Endpoint Health was selected for the 2022 @ycombinator Top Companies list. Learn more about this honor and about our company: bit.ly/3AGveF3
ENDPOINT HEALTH tweet media
English
0
5
17
0
Matthew De Silva retweetledi
Alok Tayi
Alok Tayi@aloktayi·
I'm so excited to be launching @vibe_bio - a new biotech company founded by @joshuaforman & myself to give patients with #rare + overlooked diseases access to the funding and community they need to develop treatments. vibebio.com
English
16
28
175
0
Matthew De Silva retweetledi
Bill Gurley
Bill Gurley@bgurley·
Having survived two previous market resets (2001, 2009), people frequently ask me how this 2022 market reset is different and how it is the same. The obvious similarity is that valuation multiples have collapsed. We went from a "glass very full" mindset to one with many concerns.
English
1
1.3K
7.2K
0
Vibe Bio
Vibe Bio@VibeBio·
distributed #biotech is a big thing. a running list of #startups with hub/spoke models. 🧵 👇 (6)
English
4
1
2
0

Keşfet

@BoehringerIN @jackcastle @chrisfhoward @endpts @RyFukushima @notablelabs @viswacolluru @eperlste